Erratum: Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression (Journal of Geriatric Psychiatry and Neurology (2012) 25, 1, (43-50) DOI: 10.1177/0891988712436688);Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression

Journal of Geriatric Psychiatry and Neurology

Volumn 25, Issue 1, 2012, Pages 43-50

  Forester, Brent P ^a,b   Zuo, Chun S ^a,b   Ravichandran, Caitlin ^a,b   Harper, David G ^a,b   Du, Fei ^a,b   Kim, Susan ^a   Cohen, Bruce M ^a,b   Renshaw, Perry F ^c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

bipolar depression; CoEnzyme Q10; geriatric; magnetic resonance spectroscopy (MRS); mitochondria

Indexed keywords

CREATINE KINASE; UBIDECARENONE;

ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; GERONTOPSYCHIATRY; HUMAN; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD; NAUSEA; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

EID: 84859342098     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988712450160     Document Type: Erratum

References (45)

1. Young RC, Gyulai L, Mulsant BH, et al. 3rd: Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. 2004;12(4):342-357. (Pubitemid 38878855)
2. Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry. 2005;10(10):900-919. (Pubitemid 41486483)
3. Cataldo AM,McPhie DL, Lange NT, et al. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathology. 2010;177(2):575-585.
4. Hamakawa H, Murashita J, Yamada N, et al. Reduced intracellular pH in the basal ganglia and whole brain measured by P31-MRS in bipolar disorder. Psychiatry Clin Neurosci. 2004;58(1):82-88. (Pubitemid 38200376)
5. Kato T, Takahashi S, Shioiri T, Inubushi T. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo P31 and 7Li magnetic resonance spectroscopy. J Affect Disord. 1993;27(1):53-59. (Pubitemid 23029240)
6. Konradi C, Eaton M, MacDonald ML, et al. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry. 2004;61(3):300-308. (Pubitemid 38295832)
7. MacDonald ML, Naydenov A, Chu M, et al. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord. 2006;8(3):255-264.
8. Smith CD, Landrum W, Carney JM, et al. Brain creatine kinase with aging in F-344 rats: analysis by saturation transfer magnetic resonance spectroscopy. Neurobiol Aging. 1997;18(6):617-622. (Pubitemid 28046414)
9. Spindler M, BealMF, Henchcliffe C. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009;5:597-610.
10. Balaita C, Christodorescu D, Nastase R, et al. The serum creatinekinase as a biologic marker in major depression. Rom J Neurol Psychiatry. 1990;28(2):127-134.
11. Kasparova S, Sumbalova Z, Horecky J, et al. New magnetic resonance spectroscopy biomarker for monitoring neurodegenerative diseases: Animal models. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(2):373-376.
12. Braissant O, Henry H, Loup M, et al. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res. 2001;86(1-2):193-201. (Pubitemid 32124774)
13. Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. Annu Rev Biochem. 1985;54(83):831-862. (Pubitemid 15073666)
14. Sauter A, Rudin M. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function. J Biol Chem. 1993;268(18):13166-13171. (Pubitemid 23307733)
15. Battino M, Ferri E, Gorini A, et al. Natural distribution and occurrence of coenzyme Q homologues. Membr Biochem. 1990;9(3):179-190.
16. Beyer RE. An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem Cell Biol. 1992;70(6):390-403.
17. Shults CW, Haas R. Clinical trials of coenzyme Q10 in neurological disorders. Biofactors. 2005;25(1-4):117-126. (Pubitemid 44070839)
18. Singh RB, Neki NS, Kartikey K, et al. Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem. 2003;246(1-2):75-82. (Pubitemid 36798725)
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IVTR). Washington, DC: American Psychiatric Association; 2000.
20. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Brit J Psychiat. 1979;134:382-389. (Pubitemid 9136500)
21. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435. (Pubitemid 9006756)
22. Guy W. ECDEU Assessment Manual for Psychopharmacology, in US Dept Health, Education and Welfare Publication (ADM) 76-338. Rockville, MD: National Institute of Mental health. 1976:218-222.
23. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37-49. (Pubitemid 13123113)
24. Bottomley P, Hardy C. Mapping creatine kinase reaction rates in human brain and heart with 4 Telsa saturation transfer 31P NMR. J Magn Reson. 1992;99:443-448.
25. Wallimann T, Dolder M, Schlattner U, et al. Creatine kinase: an enzyme with a central role in cellular energy metabolism. Magma. 1998;6(2-3):116-119. (Pubitemid 28465119)
26. Streijger F, Oerlemans F, Ellenbroek BA, et al. Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit. Behav Brain Res. 2005;157(2):219-234. (Pubitemid 40082565)
27. Lei H, Ugurbil K, Chen W. Measurement of unidirectional Pi to ATP flux in human visual cortex at 7 T by using in vivo 31P magnetic resonance spectroscopy. Proc Natl Acad Sci USA. 2003;100(24):14409-14414. (Pubitemid 37499250)
28. Spencer RG, Balschi JA, Leigh JS Jr, Ingwall JS. ATP synthesis and degradation rates in the perfused rat heart. 31P-nuclear magnetic resonance double saturation transfer measurements. Biophys J. 1988;54(5):921-929. (Pubitemid 18260436)
29. Du F, Xiong Q, Zhu XH, Chen W. An Improved Magnetization Saturation Transfer Approach-T1nom for Rapidly Measuring and Quantifying CK Activity in the Rat Brain. ISMRM 18th Annual Meeting; 2010:3886.
30. Xiong Q, Du F, Zhu X, et al. ATP production rate via creatine kinase or ATP synthase in vivo: a novel superfast magnetization saturation transfer method. Circ Res. 2011;108(6):653-663.
31. Rothman D. 1H NMR studies of human brain metabolism and physiology. NMR in Physiology and Biomedicine. San Diego: Academic Press; 1994:353-372.
32. Lehninger. Principles of Biochemistry. New York, NY: Worth Publishers Inc; 2000.
33. Infante AA, Klaupiks D, Davies RE. Phosphorylcreatine consumption during single-working contractions of isolated muscle. Biochim Biophys Acta.1965;94:504-515.
34. Beasley CL, Pennington K, Behan A, et al. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics. 2006;6(11):3414-3425. (Pubitemid 43886157)
35. Wallimann T,WyssM, Brdiczka D, et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J. 1992;281(pt 1):21-40.
36. Streijger F, Jost CR, Oerlemans F, et al. Mice lacking the UbCK-mit isoform of creatine kinase reveal slower spatial learning acquisition, diminished exploration and habituation, and reduced acoustic startle reflex responses. Mol Cell Biochem. 2004:256-257(1-2):305-318. (Pubitemid 38181254)
37. Suzuki A, Aoshima T, Fukasawa T, et al. A three factor model of the MADRS in major depressive disorder. Depress Anxiety. 2005;21(2):95-97. (Pubitemid 40734025)
38. Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):784-94. Epub 2010 Jul 4. Review. PMID: 20609377.
39. Maes M, Mihaylova I, Kubera M, et al. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett. 2009;30(4):462-469.
40. Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002;59(10):1541-1550.
41. http://www.ninds.nih.gov/disorders/clinical-trials/CoQ10-Trial-Update. htm.
42. http://www.ninds.nih.gov/disorders/clinical-trials/NCT00608881.htm.
43. Rosenfeldt F, Hilton D, Pepe S, et al. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors. 2003;18(1-4):91-100.
44. http://www.mayoclinic.com/health/coenzyme-q10/NS-patient-coenzymeq10. Accessed January 26, 2012.
45. Bachmann RF, Wang Y, Yuan P, et al. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharmacol. 2009;12(6):805-822.